REGN7508 Clinical Trials
4 recruitingDrug
Phase 33Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 3
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals860 enrolled12 locationsNCT07410117
Recruiting
Phase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals1,200 enrolled41 locationsNCT07175428
Recruiting
Phase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled13 locationsNCT07213778
Recruiting
Phase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905